Seegene Inc
상단으로
Contact Us

Product News You can check out the latest product information

  • Obtained CE-IVD marking for Seeplex® HPV6 ACE Genotyping

    Seeplex® HPV6 ACE Genotyping                                                                                Seegene's Seeplex® CMV ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Mar 03, 2009 Seeplex® HPV6 ACE Detection

  • Obtained Medical Device License By Health Canada : Seeplex® RV12 ACE Detection

    Simultaneous detection of 12 major respiratory viruses Obtained Medical Device License By Health Canada : Seeplex® RV12 ACE Detection

    Nov 04, 2008 Seeplex® RV12 ACE Detection

  • Received Approval from Health Canada for Seepelx® RV5 ACE Screening...

    Seeplex® RV5 ACE Screening Rapid screening of most prevalent respiratory viruses Seeplex® RV5 ACE Screening has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.NOT AVAILABLE IN US Seeplex® RV 12 ACE Detection Simultaneously detection 12 major respiratory viruses Seeplex® RV 12 ACE Detection has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.

    Nov 03, 2008 Seeplex® RV12 ACE Detection , Seeplex® RV5 ACE Screening

  • Obtained CE-IVD marking for Seeplex® HPV18 ASE Genotyping

    Seeplex® HPV18 ASE Genotyping Seegene's Seeplex® HPV18 ASE Genotyping has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Jul 31, 2008 Seeplex® HPV18 ASE Genotyping

  • Obtained CE-IVD marking for Seeplex® STD6 ACE Detection

    Seegene's Seeplex® STD6 ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union. 

    Jul 21, 2008 Seeplex® STD6 ACE Detection

  • Chlamydia product received COC by EU NB

    Seeplex® CT ACE Detection Seeplex® CMV ACE Detection Chlamydia product received COC (Certificate of conformity) by EU NB (Notified Body). ITC (Institute for Testing and Certification).

    Jul 15, 2008 Seeplex® CT ACE Detection , Seeplex® CMV ACE Detection

  • Seeplex® STD6 ACE Detection: CE-IVD Marking

    Seeplex® STD6 ACE Detection Simultaneously detecting 6 different STD pathogens Seeplex® STD ACE Detection series are designed to simultaneously detect 6 sexually transmitted disease (STD) pathogens Seeplex® STD6 ACE Detection is designed to simultaneously detect 6 sexually transmitted disease(STD) pathogens from patients' samples (urine, urethral swab, vaginal swab, genital lesion swab, cervical brush/swab or liquid-based cytology specimen (ex. ThinPrep®, specimen transport medium, etc.)). The conventional methods (ELISA, Giemsa stain, culture, etc.) to detect STD pathogens take several days or suffer from poor sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's STD Detection is outstanding in terms of sensitivity and specificity using a novel DPO™ technology and currently detects multiple pathogens causing sexually transmitted infections by Mutiplex PCR

    Jul 01, 2008 Seeplex® STD6 ACE Detection

  • Launched Seeplex® Sepsis DNA Test / Introduced at AACC

    Seeplex® Sepsis Screening SetScreening for sepsis-causing pathogensSeeplex® Sepsis Group Screening Set can screen for sepsis-causing pathogenes from periodontal and caries joint fluid, cerebrospinal fluid, blood cultures, urine, sputum, and other body fluids. * Launched Seeplex® Sepsis DNA Test * Introduced at the 2008 Annual   Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC) The conventional method for sepsis diagnostics is blood culture. However, it takes up to several days for the result. Therefore it is not appropriate for a patient in an intensive care unit. Seeplex® Sepsis Group Screeing Set enables simultaneous screening for gram-negative and -positive bacteria and fungi that cause sepsis with multiplex PCR and provides more rapid results than culture testing.

    Jul 01, 2008 Seeplex® Sepsis DNA Test